These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 11151760)

  • 1. Proinsulin C peptide obviates sympathetically mediated suppression of splenic lymphocyte activity in rats.
    Okamoto S; Kimura K; Kitamura T; Cañas X; Yoshida T; Saito M
    Diabetologia; 2000 Dec; 43(12):1512-7. PubMed ID: 11151760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interleukin-1 beta-induced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor: an in vivo microdialysis study in conscious rats.
    Shimizu N; Hori T; Nakane H
    Brain Behav Immun; 1994 Mar; 8(1):14-23. PubMed ID: 8003768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central corticotropin-releasing hormone activates the sympathetic nervous system and reduces immune function: increased responsivity of the aged rat.
    Irwin M; Hauger R; Brown M
    Endocrinology; 1992 Sep; 131(3):1047-53. PubMed ID: 1505449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinsulin C-peptide activates vagus efferent output in rats.
    Kimura K; Niijima A; Yoshida R; Kitamura T; Kamikawa A; Furuya DT; Kitamura N; Konno A; Nakamoto H; Sakane N; Yoshida T; Saito M
    Peptides; 2005 Dec; 26(12):2547-53. PubMed ID: 16005542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor.
    Sundar SK; Cierpial MA; Kilts C; Ritchie JC; Weiss JM
    J Neurosci; 1990 Nov; 10(11):3701-6. PubMed ID: 2230954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Denervation of the cervical sympathetic nerve inhibited the splenic natural killer cell activity by modulation of the splenic sympathetic nerve activities in rats].
    Okada M; Guo SY; Sunagawa M; Hisamitsu T
    Masui; 1999 Jul; 48(7):787-90. PubMed ID: 10434523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central leptin suppresses splenic lymphocyte functions through activation of the corticotropin-releasing hormone-sympathetic nervous system.
    Okamoto S; Irie Y; Ishikawa I; Kimura K; Masayuki Saito
    Brain Res; 2000 Feb; 855(1):192-7. PubMed ID: 10650150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central administration of interferon-alpha enhances rat sympathetic nerve activity to the spleen.
    Katafuchi T; Hori T; Take S
    Neurosci Lett; 1991 Apr; 125(1):37-40. PubMed ID: 1857556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered cardiovascular response to corticotropin-releasing factor in spontaneously hypertensive rats.
    Fisher LA; Overton JM
    Proc West Pharmacol Soc; 1988; 31():317-8. PubMed ID: 3264916
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequential relationship between actions of CRF and PGE2 in the brain on splenic sympathetic nerve activity in rats.
    Katafuchi T; Ichijo T; Hori T
    J Auton Nerv Syst; 1997 Dec; 67(3):200-6. PubMed ID: 9479672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity.
    Irwin M; Hauger RL; Jones L; Provencio M; Britton KT
    J Pharmacol Exp Ther; 1990 Oct; 255(1):101-7. PubMed ID: 2120421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central interleukin-1 beta enhances splenic sympathetic nerve activity in rats.
    Ichijo T; Katafuchi T; Hori T
    Brain Res Bull; 1994; 34(6):547-53. PubMed ID: 7922597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant and anxiogenic effects of corticotropin releasing factor.
    Koob GF; Thatcher-Britton K
    Prog Clin Biol Res; 1985; 192():499-506. PubMed ID: 3878524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intragastric injection of Lactobacillus casei strain Shirota suppressed spleen sympathetic activation by central corticotrophin-releasing factor or peripheral 2-deoxy-d-glucose in anesthetized rats.
    Tanida M; Takada M; Kato-Kataoka A; Kawai M; Miyazaki K; Shibamoto T
    Neurosci Lett; 2016 Apr; 619():114-20. PubMed ID: 26971699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin releasing factor increases in brown adipose tissue thermogenesis and heart rate through dorsomedial hypothalamus and medullary raphe pallidus.
    Cerri M; Morrison SF
    Neuroscience; 2006 Jun; 140(2):711-21. PubMed ID: 16580142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of LH release by CRF may be partially mediated through hypothalamic beta-endorphin release.
    Nikolarakis KE; Almeida OF; Herz A
    NIDA Res Monogr; 1986; 75():403-5. PubMed ID: 2963219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intracerebroventricular injection of interleukin-2 inhibits splenic sympathetic nerve activity].
    Li DM; Lin SX
    Sheng Li Xue Bao; 1996 Oct; 48(5):482-6. PubMed ID: 9387781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain vasopressin is involved in stress-induced suppression of immune function in the rat.
    Shibasaki T; Hotta M; Sugihara H; Wakabayashi I
    Brain Res; 1998 Oct; 808(1):84-92. PubMed ID: 9795154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathetic nervous system and lymphocyte proliferation in the Fischer 344 rat spleen: a longitudinal study.
    Bellinger DL; Silva D; Millar AB; Molinaro C; Ghamsary M; Carter J; Perez S; Lorton D; Lubahn C; Araujoa G; Thyagarajan S
    Neuroimmunomodulation; 2008; 15(4-6):260-71. PubMed ID: 19047803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.